Category Archives: Drug Development

Tinkering With Semantic Markup

One of the key challenges for bioinformaticians in this age is extracting meaningful findings from abstracts and full text articles. Text mining solutions can only take it so far, and previous comparative studies have shown that Amazon Mechanical Turk solutions and … Continue reading

Posted in Bioinformatics, Cancer Research, Drug Development, Informatics, Science Blogging, Semantic Web | Leave a comment

KNIME and Cheminformatics: A Peek Behind The Curtain

Part of what makes user group meetings so interesting is getting the opportunity to peek behind the curtains and see someone else’s operation.  In last night’s, KNIME user group meeting, Brock Luty of Dart NeuroScience gave an interesting perspective on … Continue reading

Posted in Drug Development, Informatics, Science Blogging | Tagged , , | Leave a comment

SwissModel: It’s not what you think

One of the things that I’m always curious about, is the effect of a sequence variation on the conformation of a target.  Recently I wrote about ClinVar and SwissVar, two tools for examining variants and their associations with disease.  Since … Continue reading

Posted in Bioinformatics, Drug Development, Informatics, Science Blogging | Tagged , , , | Leave a comment

Merrimack’s New Pancreatic Cancer Drug

The intertubes have been abuzz lately with the news of Merrimack’s results from their Phase III trial of a new triplet therapy for pancreatic cancer.  The triplet combines older standard of care drugs like 5FU and leucovorin with their new … Continue reading

Posted in Drug Development, pancreatic cancer | Tagged , | Leave a comment

Notes from San Diego KNIME User Group Meeting

This week Brock Luty of Dart Neuroscience hosted the first San Diego KNIME User Group meeting.  Michael Berthold, one of the founders of KNIME, came down from San Francisco to deliver a briefing Mark Donnelly of XIFIN demonstrated how a … Continue reading

Posted in Drug Development, Informatics | Tagged , , , , | Leave a comment

Promising Preclinical Results in Pancreatic Cancer

A recent announcement at the AACRs-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19–23, points to some promising results in recent trials that targeted multiple pathways downstream of KRAS (including PI3K/AKT, RAF/MEK/ERK and RAL).  The studies conducted … Continue reading

Posted in Cancer Research, Drug Development, pancreatic cancer | Tagged , , , | Leave a comment

Cui Bono? Finding Super Responders In Clinical Trials

I’m a voracious reader of mysteries in my spare time.  And some juncture in every story, as the detective finds himself staring at the corpse, they ask the inevitable question “Cui Bono — who benefits?”  Oddly enough, this is a … Continue reading

Posted in Cancer Research, Drug Development, Informatics, pancreatic cancer | Tagged , , | Leave a comment

ClinVar – A database of mutations and their clinical relevance

One of the key pieces of the drug discovery puzzle involves determining the clinical relevance of the target.  Over the past few years big pharma have been pulling back from this critical part of the drug discovery process and ceding … Continue reading

Posted in Bioinformatics, Drug Development, Informatics, pancreatic cancer | Tagged , , , , | 2 Comments

Latest Pancreatic Cancer Articles

During the recent ASCO GI conference, the big news was the release of the results of the Abraxane trials.  The data show that the lives of pancreatic cancer patients can be extended by two months when adding Abraxane into the … Continue reading

Posted in Drug Development, pancreatic cancer | Tagged , , , , | Leave a comment

Latest Pancreatic Cancer News & Articles

News In this weeks news: ABRAXANE Demonstrates Statistically Significant Improvement in Overall Survival for Patients with Advanced Pancreatic Cancer in Phase III Study – Yahoo! Finance MONTPELLIER, France: Skuldtech and AB Science Announce the Identification of New Predictive Markers for … Continue reading

Posted in Drug Development, pancreatic cancer, Uncategorized | Tagged , | Leave a comment